Array
(
    [0] => stdClass Object
        (
            [id] => 1101
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => dsc01297-compressed.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2023-06-19
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2023-06-19 14:45:12
            [updated_time] => 2023-08-22 16:37:30
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => gentis-tham-gia-hoi-nghi-san-phu-khoa-toan-quoc-2023-vago
            [title] => GENTIS participates in the 2023 National Congress of Obstetrics and Gynecology (VAGO)
            [description] => The 2023 National Congress of Obstetrics and Gynecology is a major annual event of the Vietnamese health sector, organized by the Vietnam Association of Obstetricians and Gynecologists (VAGO). The conference took place on the morning of June 15, 2023, attracting the participation of more than 500 national and international experts in obstetrics and gynecology, leading clinicians and technical experts. GENTIS is honored to provide the report data to MSc Nguyen Viet Quang (Director of the Center for Reproductive Support of the National Hospital of Obstetrics and Gynecology) with the topic: “Personalization and Optimization of the Embryo Transfer Window: ROLE SUPPORT OF GENE TESTING AND EFFICIENCY IN CLINICAL APPLICATION”.
            [content] => 

The 2023 National Congress of Obstetrics and Gynecology was held with the goal of exchanging experiences and presenting new scientific findings in the fields of health, prenatal diagnosis, gynecology, oncology, obstetrics, and support. fertility… Attending the conference were representatives of leaders of the Ministry of Health such as: Prof. Dr. Nguyen Viet Tien (Former Deputy Minister of Health, Chairman of the Vietnam Association of Obstetricians and Gynecologists); BS. Dinh Anh Tuan - Director of the Department of Maternal and Child Health, Ministry of Health; together with leading experts from FIGO, AOFOG, VAGO such as GS. Pisake Lumbiganon - President of AOFOG, Prof. Philippe Descamps - Vice President of the International Federation of Obstetrics and Gynecology (FIGO) and more than 500 delegates who are active in the field of obstetrics and gynecology come from major domestic and international hospitals and centers.
The conference took place in 2 days, June 15-16, 2023 with 9 thematic sessions, 5 satellite seminars and 49 attractive reports on important topics in the field of obstetrics and gynecology, typically:
• Interventional surgeries in assisted reproductive technology - Prof. Dr. Nguyen Viet Tien (Chairman of Vietnam Association of Obstetricians and Gynecologists)
• Research on cystic lymphatic malformations at the National Hospital of Obstetrics and Gynecology - Assoc. Prof. Dr. Tran Danh Cuong (Director of the National Hospital of Obstetrics and Gynecology, Standing Vice President of VAGO)
• WHO perinatal care for a positive birth experience - Prof Pisake Lumbiginon (AOFOG President)
• Short-term and long-term effects of cesarean section on women's health - Dr.U.D.P.Ratnasiri (MFM committee chair)
• Prevention of first caesarean section - Dr Rohana Haththotuwa (AOFOG Secretary)
Before the conference, the delegates participated in a course with the theme "For the sustainability of minimally invasive surgery: from basic to advanced" with the participation of leading experts in Vietnam and world. At the conference, the Symposium on Reproductive Support was interested by many doctors and experts. Especially the knowledge of new tests that are clinically effective for assisted reproductive treatment

At this discussion session, MSc Nguyen Viet Quang (Director of the Center for Reproductive Support of the National Hospital of Obstetrics and Gynecology) presented a report with the research topic: “Personalization and Optimization of the Embryo Transfer Window. : ROLE OF GENE TESTING AND EFFICIENCY IN CLINICAL APPLICATION”. This is one of the presentations that many delegates are interested in because of the urgency and practical application of the topic. GENTIS is honored to provide data reported to MSc Nguyen Viet Quang (Director of Center for Obstetrics and Gynecology, Central Obstetrics and Gynecology) in this topic.
️Genratest is a genotypic expression-based analytical test used to determine the optimal timing for embryo transfer (window period). Currently, the use of the Genratest Embryo Transfer Window test has been used in Vietnam and initially has had good signals.
In the world, there are many different views about the effectiveness of Genratest. However, according to the report of Ths.BS Viet Quang, there have been studies in Vietnam that have brought positive results for patients with failed implantation many times, coming from the research of Dr. Ly Thai Loc and Dr. partner:
• Pregnancy rates are raised to par with the population of patients without multiple implantation failures
• Expectation of live birth is higher than normal

 
GENTIS is honored to be the provider of Genratest test in Vietnam and is conducting many clinical studies to support doctors in assisted reproductive treatment. The tests of GENTIS promise to bring great significance in the diagnosis, treatment and development of obstetrics and gynecology in particular and the country's medicine in general. Once again, GENTIS would like to wish the National Congress of Obstetrics and Gynecology 2023 well.
            [content_more] => 
            [meta_title] => GENTIS participates in the 2023 National Congress of Obstetrics and Gynecology (VAGO)
            [meta_description] => 
            [meta_keyword] => 
            [thumbnail_alt] => 
            [post_id] => 1101
            [category_id] => 4
        )

    [1] => stdClass Object
        (
            [id] => 1097
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => pgt-m-2.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2023-06-09
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2023-06-09 13:17:43
            [updated_time] => 2023-08-22 15:26:26
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => y-nghia-va-tam-quan-trong-cua-pgtm-voi-gia-dinh-mac-benh-di-truyen-de-sinh-con-khoe-manh
            [title] => Significance and importance of PGT-M for families with genetic diseases to have healthy children
            [description] => PGT-M is a test to detect genetic mutations that cause disease in embryos that are inherited from one parent or both parents before being selected for transfer into the uterus - a method to help mothers with in vitro fertilization (IVF) give birth to a healthy baby. Thereby improving the quality of embryo transfer and giving birth to healthy babies.
            [content] => 
1. What is the PGT-M test?
PGT-M is a pre-embryo transfer genetic test for monogenic inherited diseases. With this test, we can test the embryo's genome very early, helping to detect abnormal passages on a particular gene inherited from parents.
From there, the embryos that are homozygous for the disease gene will be removed before being transferred to the mother's uterus. The effectiveness of the PGT-M test has been shown to limit the number of babies born with thalassemia and the need to terminate the pregnancy mid-term when the fetus has severe anemia abnormalities.

Not only effective in diagnosing thalassemia, the PGT-M test also helps diagnose many other single-gene diseases in embryos such as X-linked genetic diseases, dystrophy Duchenne muscle, Hemophilia,... Moreover, in the future, this test is also aimed at treating siblings of children who have been born but have the disease.
In addition, the PGT-M test can diagnose the human leukocyte antigen (HLA) match of the embryo with the affected sibling. Stem cells from the cord blood of children born from embryos selected through PGT-M will help treat siblings with the disease.
2. Who should perform the PGT-M test?
The PGT-M test is ordered by the doctor in cases where there is a history of a husband or wife carrying the disease gene, or in the family there is an inherited disease caused by a gene mutation such as monodominant inherited diseases (eg. Huntington's disease), monogenic recessive diseases (eg, cystic fibrosis), chromosomal disorders (eg, numerical or structural abnormalities), sex-linked disorders (eg, Duchenne muscular dystrophy), predictors of cancer (cervical cancer, breast cancer, etc.) or determine HLA compatibility (to select embryos compatible with HLA antigens with siblings). have a disease that requires blood transfusion, marrow transplant. This child can later cure the disease, donate marrow for brother/sister).
For patients at risk of passing a genetic disease on to their children, PGT-M reduces the risk and increases the likelihood of having a healthy baby. Also avoid emotionally and ethically challenging decisions when deciding whether to terminate a pregnancy if the fetus has a genetic abnormality.
In clinical practice, PGT-M is often combined with the PGT-A/SR test to comprehensively assess embryo quality and improve the success rate of assisted reproduction methods. Patients with single-gene disorders are mostly young and have a good prognosis, but their risk of spontaneous abortion is still quite high. In recent years, many studies have reported that when embryos are combined with PGT-M and PGT-A screening, the pregnancy rate can increase from 45 to 68% and the rate of spontaneous abortion decreases from 15% to 15%. 5%.
In addition, the combination of PGT-A screening is appropriate for the majority of women undergoing IVF. All women are at risk of producing embryos with chromosomal abnormalities (trisomy 13, 18, 21), and as maternal age increases, the likelihood of embryos with chromosomal abnormalities increases. However, the PGT-A test can help women of all ages increase their chances of successful fertilization and embryo transfer.
3. How is the PGT-M test done?
Basically, to perform the PGT-M test, couples need to be assisted with IVF. The generated embryos will be raised to day 5.
With the eligible embryos on day 5 (blastocysts) will be biopsied (removing 3 - 5 embryonic cells from the cell area that will develop into the placenta later). Cell samples after biopsy will be applied special testing methods to detect disease-carrying genes.

With modern medicine, today, we can also perform the ASEM test on the embryo culture medium sample without the need for an embryo biopsy. With this technique, we do not need to worry about possible effects on the embryo during the biopsy.
4. The purpose of PGT-M for families with inherited diseases to have healthy children
According to research, the current infertility rate in Vietnam accounts for 7.7%, of which the causes are equal to men and women, accounting for 40% of each gender and 20% of unknown causes. The development and rapid progress of genetic engineering and technologies have greatly benefited the field of assisted reproduction right from the pre-implantation embryo stage.
The PGT method (pre-implantation embryo screening) has greatly contributed to the selection of the healthiest embryos before implantation in the uterus, increasing the chances of pregnancy, reducing the number of cycles of in vitro fertilization and the cost of pay. In addition, PGT-M is a test to identify abnormalities, single gene mutations associated with some genetic disease syndromes such as Thalassemia, Hemophilia, muscular atrophy, polycystic kidney, RETT syndrome,... PGT -M is indicated for couples who carry a disease-causing mutation and are at high risk of having a child with a monogenic disease.
The effectiveness of the PGT-M test has been clearly demonstrated to help limit the situation of babies being born with the disease, limiting the need to terminate the pregnancy midway when the fetus has an abnormal diagnosis. With dangerous genetic diseases, the implementation of prenatal genetic screening and diagnosis is no longer an individual affair of a family, but a long-term step with the contribution of society in general and the medical profession. economy in particular.
For the purpose of improving, improving the quality of the race, and the prosperity of society, PGT-M will improve the status of children born with birth defects, serious genetic diseases and non-reproductive abnormalities. desired in couples.
5. GENTIS - Comprehensive gene ecosystem for Vietnamese people
With the desire to bring the best fertility support methods to doctors and patients in Vietnam, GENTIS has constantly researched, developed, and applied the PGT-M test in preimplantation embryo screening with rare diseases. Not only effective in diagnosing Thalassemia, PGT-M technique also helps diagnose many other rare genetic diseases of embryos such as myelodysplasia, Duchenne muscular dystrophy, hemophilia, osteochondrotic dysplasia. , congenital adrenal hyperplasia, hemophagocytic syndrome, marfan syndrome, autosomal dominant polycystic kidney, iris defect, congenital hearing loss, RETT syndrome,...
At GENTIS, along with the application of new technical technologies, using modern machinery systems (new generation DNA sequencing system NGS Illumina - USA, Veriseq PGS technology) and specialized analysis software Using (STR, SNP analytical methods), the PGT-M test was developed and performed rigorously to provide the most reliable results.

Combining PGT-M screening for single-gene genetic disease with PGT-A screening for aneuploidy embryos will help couples select embryos that do not carry genetic abnormalities to be screened for embryo transfer. With modern technology increasingly developed, GENTIS hopes to deploy, research, and successfully test many other rare genetic diseases, contributing to the successful preimplantation screening process and healthy babies for every family.
With a system of 2 laboratories meeting ISO 9001:2015, ISO 15189:2012 and the ability to perform tens of thousands of tests per year, GENTIS always aims to develop gene technology suitable for Vietnamese people, bringing has great value in the diagnosis, treatment of diseases and assisted reproduction. In particular, GENTIS is increasingly asserting its outstanding position in the field of genetic analysis, maintaining full trust for customers and partners.
            [content_more] => 
            [meta_title] => Significance and importance of PGT-M for families with genetic diseases to have healthy children
            [meta_description] => 
            [meta_keyword] => 
            [thumbnail_alt] => 
            [post_id] => 1097
            [category_id] => 4
        )

    [2] => stdClass Object
        (
            [id] => 1094
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => top10_thuong_hieu_uy_tin_chau_a/kait0641.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2023-05-29
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2023-06-02 14:54:40
            [updated_time] => 2023-08-22 15:49:36
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 0
            [language_code] => en
            [slug] => gentis-tiep-tuc-vinh-danh-top-10-thuong-hieu-uy-tin-hang-dau-chau-a-2023
            [title] => GENTIS continues to be honored "TOP 10 PRESTIGE BRAND IN ASIA 2023"
            [description] => Following the title of Top 5 Vietnamese Brands received in December 2022, GENTIS affirms its brand in the medical field not only in Vietnam but also reaching out to Asia with the "TOP 10 TRADE" certification. THE LEADING PRESTIGE BRANDS in Asia 2023".
            [content] => 

Genetic Analysis Services Joint Stock Company (GENTIS) is a pioneer in the field of genetic analysis in Vietnam, providing solutions and tests in many fields such as reproductive support, obstetrics and gynecology. , gynecology, paediatrics, DNA testing...
Over 13 years of establishment, GENTIS company has grown strongly with outstanding reputation and quality, including 2 international standard testing offices in Hanoi and Ho Chi Minh City and more than 50 sampling points nationwide. GENTIS has become a reliable service provider for nearly 300,000 customers, 12 foreign partners and more than 100 partners who are major hospitals in Vietnam.

On May 27, GENTIS Company was honored to receive the title "TOP 10 PRESTIGE BRAND IN ASIA 2023" - ASIA's TOP TRUSTED BRAND AWARDS 2023 in the announcement ceremony taking place at the Military Theater (HCMC). The award is evaluated by the Asian Business Development Research Center in collaboration with international organizations based on brand evaluation criteria.
From thousands of applications from businesses, the Appraisal Council has screened and selected over 100 typical business brands that are highly appreciated and trusted by the consumer community. After a close and rigorous voting period, GENTIS company excelled in the TOP 10 when meeting the following criteria:
• Being a prestigious and leading brand in the Asian market
• Quality products and services in Vietnam and export to Asia market
• Sustainable development strategy in the Asian market
• Important contribution to the regional economy
• Social responsibility, community
• Comply with regulations on Environment, Customs, Tax, etc.
• Registering for trademark protection in Vietnam and Asian markets
In addition, the Voting Council also evaluates other specific criteria of the company such as: Capacity; Management philosophy; Technological - creative activities; Financial capacity; Human Resources; Marketing strategy;…
As a certificate of these achievements, GENTIS Company has deservedly received the award "TOP 10 PRESTIGE BRAND IN ASIA 2023", a prestigious title for businesses with the leading brand not only in Vietnam but also reaching out to Asia.
Representative of GENTIS company receiving the trophy and certificate of Asia's leading prestigious brand 2023
GENTIS - Bringing a comprehensive genetic ecosystem to Vietnamese people
With a long history of construction and development, GENTIS Company has constantly grown and risen to occupy a pioneering position in the field of genetic analysis and molecular biology. Predecessor from the Center for DNA Sequentialing and Testing, GENTIS has expanded over time to hundreds of other services in the fields of assisted reproduction, obstetrics, paediatrics, gynecology, and immunohematology. …, ready to provide a comprehensive genetic ecosystem for Vietnamese people:

• Adult, premarital testing: HPV-Eprep Cervical Cancer Screening; Pre-marital examination package; Testing for Thalassemia, Thrombophilia, muscular atrophy.
Male and female fertility support test:

- Female: Genetic analysis before PGTest embryo transfer; Analysis of ASEM Test embryo culture environment; Define GENRATEST embryo transfer window; Karyotype Chromosome Test; Antiphospholipid test, NK cells GENNK…
- Men: Sperm DNA fragmentation test; AZF test, anti-sperm antibodies, Sperm aneuploidy, CFTR gene mutation; Testing for sexually transmitted diseases (STDs)…

• Testing for Women to monitor pregnancy: GenEva Advanced Prenatal Screening; Double test & Triple test; Pre-eclampsia testing…
• Testing for Newborns and Children: Newborn screening for common dangerous diseases; Nutrition & allergy testing packages for children; Other Pediatric Tests…
• Testing for Older Adults: Genetic Cancer Genetic Tests; Health test packages: general, cancer screening…





Large scale genetic testing unit in Vietnam
Sharing after the event honoring the Top 10 "Asia's leading prestigious brands", Dr. Pham Dinh Minh - Director of GENTIS Research and Development Center said:
“I am very happy and proud when GENTIS continuously receives the top titles in Vietnam and reaches out to Asia. Overcoming thousands of applications from big and prestigious brands, we were honored to receive this title. This is also the goal of GENTIS in the coming years after joining Eurofins Scientific: Connecting to international integration and cooperating to provide genetic testing services globally.

Dr. Pham Dinh Minh - Director of Research and Development Center of GENTIS . company
As a reputable partner of more than 100 major medical units in the country and gene analysis organizations in the world (Illumina, Qiagen, Sigma, Genoma...), GENTIS is committed to putting the interests of customers and partners first. The first goal is to fulfill the mission of contributing to the physical and intellectual improvement of the Vietnamese people.
After the valuable titles that the company has achieved over the years, GENTIS will strive to achieve even more great success, set a firm footing in the international arena and bring customers, valued Providing the latest services with international standard quality, ensuring the highest accuracy in Vietnam.
            [content_more] => 
            [meta_title] => GENTIS continues to be honored "TOP 10 PRESTIGE BRAND IN ASIA 2023"
            [meta_description] => 
            [meta_keyword] => 
            [thumbnail_alt] => 
            [post_id] => 1094
            [category_id] => 4
        )

    [3] => stdClass Object
        (
            [id] => 1093
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => bv_an_duc_thai_binh/dsc09062.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2023-05-15
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2023-06-02 14:30:19
            [updated_time] => 2023-08-22 16:02:25
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 0
            [language_code] => en
            [slug] => gentis-don-vi-dong-hanh-chinh-thuc-tai-hoi-thao-khoa-hoc-benh-vien-phu-san-an-duc
            [title] => GENTIS: Official companion at the Scientific Conference of An Duc Obstetrics and Gynecology Hospital
            [description] => On the morning of May 13, 2023, An Duc Obstetrics and Gynecology Hospital held a Scientific Conference on Infertility - Obstetrics and Gynecology with the theme "After 1 year of IVF" in ThaiBinh City. GENTIS Company is honored to be the main partner of the program.
            [content] => 
The scientific conference Infertility - Obstetrics and Gynecology Thai Binh ended successfully and left a deep impression on doctors and specialists in the field of obstetrics and gynecology across the country. Participating in the program were the leadership of An Duc Obstetrics and Gynecology Hospital: Dr. Doan Duy Manh - Director of the Hospital; Dr. CCII Phan Quang Mac, Deputy Director of the Hospital; Dr. Do Thi Ha - Head of IVF Lab; Dr. Doan Van Khu - Head of An Duc IVF Center;... and representatives from Tu Du Hospital: Dr. Nguyen Tran Quoc Hai; MSc. Nguyen Thien Thuc…

The conference is a special occasion to look back on 8 years of establishment and development of An Duc Obstetrics and Gynecology Hospital and celebrate 1 year of operation of An Duc IVF Center (IVF An Duc). Currently, An Duc Obstetrics and Gynecology Hospital is the first fertility support unit in Thai Binh and neighboring provinces. A special feature is that An Duc IVF Center is invested with a European standard equipment system and gathers a team of leading experts in the field of infertility and infertility.
With high professional competence and warm hearts of medical staff, An Duc IVF Center is a reliable address where infertile couples have access to the best infertility treatments. Therefore, infertile couples can give their full trust on the journey to find their beloved child.
The seminar attracted the attention and attention of nearly 400 obstetricians from many provinces and cities across the country. At the Conference, many reports and lively discussions on the topic of Obstetrics and Gynecology and reproductive support were shared such as:
• Report of 8 years and a journey of An Duc An Duc Obstetrics and Gynecology Hospital - Doctor of CKII Phan Quang Mac, Deputy Director of An Duc PS Hospital
• IVF An Duc 1 year looking back to reach further - Embryologist, Doctor Do Thi Ha, Head of IVF An Duc Lab
• Summary report of Center for Reproductive Support at An Duc Hospital - Dr. Doan Van Khu, Head of An Duc IVF Center
• Fertility support, short-term and long-term outcomes - Dr. Nguyen Tran Quoc Hai, Tu Du Hospital
• Discussion on the issue of How people can access IVF at PS An Duc Thai Binh Hospital and professional cooperation with Tu Du Hospital - MSc. Nguyen Thien Thuc, Deputy Head of Tu Du Hospital's lab

Summing up the scientific conference, Dr. Doan Duy Manh - Director of An Duc Obstetrics and Gynecology Hospital gave a speech on the professional operation of the hospital. At the same time, it affirms that the technique of specialized obstetrics and gynecology and reproductive support at An Duc Hospital is well-invested, methodical, and has been transferred from major units such as the National Hospital of Obstetrics and Gynecology, the Tu Du hospital. 
In the future, An Duc Obstetrics and Gynecology Hospital will continue to implement infertility treatment by surgical methods, and focus on the effectiveness of assisted reproductive treatment, individualization of treatment regimens, etc.

In the past time, the development of An Duc IVF Center could not be without the companionship of high-tech genetic testing units. As a partner accompanying An Duc Obstetrics and Gynecology Hospital, GENTIS is honored to provide and sponsor tests in the field of assisted reproductive technology such as:
• Karyotype test: diagnosing chromosomal abnormalities to determine the cause of miscarriage, infertility, and infertility
• FSH receptor gene polymorphism test: determine the cause of poor ovarian response, evaluate cases with high risk of ovarian hyperstimulation.
In addition, GENTIS also provides many tests in the field of assisted reproduction, obstetrics and gynecology such as: Pre-implantation genetic analysis PGTest, Analysis of embryo culture environment ASEM test, Determination of GENRATEST embryo transfer window , Screening for birth defects NIPT-GENEVA, Testing for Thalassemia, Thrombophilia,...

It is hoped that the tests that GENTIS sent to An Duc Obstetrics and Gynecology Hospital in particular and fertility support centers across the country will provide maximum support for doctors and specialists in diagnosis and assisted reproductive treatment, obstetrics and gynecology.
The end of the seminar left an unforgettable impression with the entire leadership, staff at An Duc Hospital for Obstetrics and Gynecology, as well as specialists from all over the country who came to participate. Hopefully in the future, An Duc Obstetrics and Gynecology Hospital will continue to cooperate with GENTIS to improve service quality and bring complete happiness to infertile couples in Thai Binh, as well as neighboring provinces.
            [content_more] => 
            [meta_title] => GENTIS: Official companion at the Scientific Conference of An Duc Obstetrics and Gynecology Hospital
            [meta_description] => 
            [meta_keyword] => 
            [thumbnail_alt] => 
            [post_id] => 1093
            [category_id] => 4
        )

    [4] => stdClass Object
        (
            [id] => 1092
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => gentis-cho-con-khoi-dau-ven-toan-bv-thanh-nhan.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2023-05-30
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2023-05-30 08:45:59
            [updated_time] => 2023-08-22 16:21:07
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => gentis-dong-hanh-cung-chuong-trinh-cho-con-yeu-khoi-dau-ven-toan-tai-bv-thanh-nhan
            [title] => GENTIS accompanies the program "Give your baby a perfect start" at Thanh Nhan Hospital
            [description] => From June 1, 2023 - July 1, 2023, GENTIS is pleased to accompany the program "Give your baby a perfect start" at the Department of Obstetrics and Gynecology 2 - Thanh Nhan Hospital. This is a program dedicated to pregnant women with the desire to join hands to improve the quality of the population in Vietnam. GENTIS is honored to be the main sponsor of the program.
            [content] => 
According to statistics from the General Department of Population and Family Planning, in Vietnam each year, more than 1 million children are born, of which about 22,000 to 30,000 children have birth defects. With good prenatal and neonatal screening and diagnosis, about 1,700 children with severe congenital hemolytic anemia (Thalassaemia), 1,400 children with Down syndrome, 500 children with neural tube defects, 200 children with hypothyroidism congenital condition, 10,000 to 20,000 children have G6DP deficiency and many other genetic diseases. In addition, there are also about 60% to 70% of malformations, birth defects so far the cause is still unknown.
This is not only a pain for the child but also a burden for the family and the whole society. Therefore, to ensure the future development of the baby, experts and doctors recommend that families perform NBS right from the time the child is born.
NBS is a test to help detect congenital diseases as early as 48 hours after birth, so that timely interventions can be taken to minimize the damage and development of the child. Mothers can rest assured that their babies will be born healthy, free from common or rare birth defects, and help their children grow steadily and healthy in the future.
Understanding the importance of NBS, GENTIS cooperates with Thanh Nhan Hospital to organize the program "Give your baby a FULL START" to accompany doctors and experts to provide comprehensive health care for newborns. . In particular, GENTIS will immediately give 1 baby clothes when customers register for examination and birth at Department of Obstetrics and Gynecology 2 - Thanh Nhan Hospital.
The gift set for the children is a small gift that GENTIS wants to join hands with Thanh Nhan Hospital to gradually popularize NBS testing more widely to the people of Vietnam. Above all, GENTIS currently offers a variety of NBS test packages for common and common congenital diseases as well as metabolic disorders, giving postpartum mothers the right choice for each person.
GENTIS hopes that the program "Give your baby a perfect start" will contribute to creating human values for babies, with the goal of early screening for abnormal problems that may affect the development. children, help prevent complications, help children develop normally both physically and mentally. At the same time, contributing to the sustainable and strong development of the NBS segment in our country.
Let's update more information about the program "Give your baby a perfect start" at GENTIS Website and Fanpage!
            [content_more] => 
            [meta_title] => GENTIS accompanies the program "Give your baby a perfect start" at Thanh Nhan Hospital
            [meta_description] => 
            [meta_keyword] => 
            [thumbnail_alt] => 
            [post_id] => 1092
            [category_id] => 4
        )

    [5] => stdClass Object
        (
            [id] => 1091
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => gentis-cap-nhat-dich-vu-1.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2023-05-27
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2023-05-27 08:19:24
            [updated_time] => 2024-06-19 16:53:26
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => hoi-thao-cap-nhat-dich-vu-sang-loc-truoc-sinh-va-xet-nghiem-ung-thu-co-tu-cung-tai-bv-da-khoa-quoc-te-ha-noi-bac-giang
            [title] => Workshop to update services of prenatal screening and cervical cancer testing at Hanoi - Bac Giang International General Hospital
            [description] => On May 25, 2023, GENTIS cooperated with Hanoi - Bac Giang International General Hospital to organize a seminar to share non-invasive prenatal screening testing services NIPT GenEva and cervical cancer testing. HPV uterus for medical staff at Hanoi - Bac Giang International General Hospital.
            [content] => 
The seminar to update information on testing services is a regular activity that GENTIS is implementing with partners and customers. Following this series of activities, GENTIS collaborated with Hanoi - Bac Giang International General Hospital to organize a workshop to update the NIPT GenEva prenatal screening service and cervical cancer testing on the afternoon of the same day. On May 25, 2023, with the participation of nearly 40 doctors and nurses working at the Hospital. GENTIS company is honored to have the participation of Ms. Le Thi Hong Nhung - Product Management Department.

At the seminar, reporter Nhung directly shared the latest information about the NIPT GenEva test at GENTIS. GenEva non-invasive prenatal screening by extraction of fetal cfDNA in maternal blood is a technology trend that is absolutely safe for mother and fetus.
GenEva test helps to detect early syndromes related to abnormal number of chromosomes in fetus with high accuracy (more than 99%), thereby minimizing unnecessary amniocentesis. The GenEva test is performed from the 10th week of pregnancy and is recommended for all high-risk pregnant women.
GENTIS is the first DNA laboratory in Vietnam to be certified with ISO 9001:2015. GENTIS is also the first unit in Vietnam to obtain ISO 15189:2012 certificate of laboratory quality management for non-invasive screening (NIPT). This is a standard that specifies competence and quality requirements for medical laboratories.

Besides, reporter Le Thi Hong Nhung also shared details about HPV cervical cancer testing at GENTIS. Cervical cancer is the result of persistent infection of the vagina and cervix by a virus of the human papillomavirus (HPV) family.
More than 80% of women followed over time will be infected with at least one HPV infection, which indicates its widespread and transmissible nature. Cervical cancer screening by HPV DNA test in combination with cytology test will help early detection and accurate assessment of the patient's risk status, helping doctors/specialists make indications. prompt and effective treatment.
To screen for cervical cancer most effectively, it is necessary to combine two methods:
• HPV test (DNA-HPV), the sample is checked for the presence of HPV strains
• Cytological test (E-Prep), the sample will assess the extent of cell damage
• Two complementary methods for doctors to give appropriate indications
As one of the early adopters of cervical cancer testing in Vietnam, GENTIS provides a complete set of high-quality cervical cancer screening tests to help women easily check their health. and early detection of disease. In addition, GENTIS also participates in and implements many counseling and guidance programs for the community, in order to raise awareness about cervical cancer, and help people know how to prevent and treat the disease effectively.

At the end of the seminar, doctors at Hanoi - Bac Giang International Hospital had a lively discussion with GENTIS representatives about GenEva prenatal screening and cervical cancer testing services. HPV. After this service report, GENTIS hopes that the doctors will bring customers many useful tests and contribute to raising the awareness of health care of the Vietnamese people.
            [content_more] => 
            [meta_title] => Workshop to update services of prenatal screening and cervical cancer testing at Hanoi - Bac Giang I
            [meta_description] => 
            [meta_keyword] => 
            [thumbnail_alt] => 
            [post_id] => 1091
            [category_id] => 4
        )

    [6] => stdClass Object
        (
            [id] => 1088
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => gentis-tai-tro-casa-dei-bambini-2.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2023-05-23
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2023-05-23 11:27:24
            [updated_time] => 2023-08-23 08:59:17
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => gentis-tai-tro-le-tong-ket-nam-hoc-2022-2023-tai-truong-mam-non-casa-dei-bambini
            [title] => GENTIS sponsors the Closing Ceremony for the 2022 - 2023 school year at Casa dei Bambini . Kindergarten
            [description] => On May 20, 2023, the closing ceremony of the school year and the summer music festival 2022 - 2023 at Casa dei Bambini Kindergarten took place successfully. GENTIS is honored to be one of the main sponsors of the program.
            [content] => 
On the morning of May 20, 2023, Casa dei Bambini Kindergarten held the closing ceremony of the school year and the Summer Music Festival 2022 - 2023 in a joyful, exciting and exciting atmosphere at the International Bilingual School Hanoi Academy. The theme of this year's event is "Maiden voyage" with the meaning that the children have completed their study journey and are preparing to enter a new phase of their life journey.
The ceremony was honored to welcome Mr. Nguyen Quang Vinh, Director of GENTIS Testing Center; Management board, teachers, more than 500 parents and students of Casa dei Bambini Kindergarten.

The Closing Ceremony is the most memorable and meaningful moment for each member of Casa dei Bambini. This is an opportunity for parents, teachers and children to have a happy time, gather in the same audience, and review the good memories during the child's growing up journey over the past year. This is also an occasion for Casa dei Bambini to honor the efforts, efforts as well as honor the most outstanding imprints of teachers and students under the beloved school roof.
At the ceremony, mother Thai Minh - Tokyo class shared: “Casa dei Bambini has become the second home of the children. With the warm care and teaching of the teachers, the children have gradually become global child citizens, imbued with Vietnamese cultural identity. They have critical skills, their own opinions and have good language reflexes to attend any primary school they desire. On behalf of all parents, I would like to express my sincerest thanks to the Board of Directors, teachers and all staff of the school. Wishing the teachers, the school's Board of Directors a lot of health to continue their career of growing people. May your school always be a warm home for other parents to safely entrust their children with."

In particular, the stage of the Summer Festival and Congress 2022 - 2023 with the theme: "Maiden voyage" is designed with sparkling lights with joyful and lively sounds. Wearing a special bachelor's uniform, confidently standing on the stage and showing her musical talent with pure lyrics, vibrant dances or creative musicals,...
 
The highlight of the ceremony was the draw for parents with valuable prizes. GENTIS is pleased to sponsor 6 Happy health cards for the program. With the Happiny health card, parents and students will easily perform tests at home, thereby saving the most time and costs.

Mr. Nguyen Quang Vinh - Director of GENTIS Testing Center shared, he feels very happy and honored when GENTIS is accompanied by the program. This is a very meaningful event for the students of Casa dei Bambini Kindergarten. He hopes that GENTIS will have more opportunities to accompany Casa in the future to help teachers, parents and students have good health to be confident, create the beginning for the development steps later.
With 13 years of experience in the testing field, GENTIS is a reliable address, trusted by major firms in the world, hundreds of major hospitals across the country and more than 300,000 customers. With the mission of improving the physical and mental health of Vietnamese people, GENTIS always tries to strive every day to develop and improve testing services, step by step join hands to bring happiness and smiles to families. families across the country.
            [content_more] => 
            [meta_title] => GENTIS sponsors the Closing Ceremony for the 2022 - 2023 school year at Casa dei Bambini . Kindergar
            [meta_description] => 
            [meta_keyword] => 
            [thumbnail_alt] => 
            [post_id] => 1088
            [category_id] => 4
        )

    [7] => stdClass Object
        (
            [id] => 1087
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => z4338970847226_476ff053ba553f6719033aa69e5dca4f.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2023-05-19
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2023-05-22 11:22:00
            [updated_time] => 2023-08-23 09:16:46
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => tu-van-di-truyen-cung-chuyen-gia-chuyen-phoi-the-kham-thuc-te-lam-sang-va-xu-tri
            [title] => Genetic counseling with experts: "Mosaic embryo transfer - Clinical reality and management"
            [description] => On May 12, 2023, GENTIS broadcasted the Talkshow "Genetic Counseling - Discuss with Experts" with the topic "Mosaic Embryo Transfer - Clinical Reality and Management". The program focused on answering questions about Mosaic Embryos and PGT nesting genetic screening, receiving a lot of attention from doctors and audiences across the country.
            [content] => 
Following the success of the previous talkshows "Genetics Counseling - Discussing with Experts", in this topic, GENTIS is honored to be accompanied by two leading experts in the field of reproductive support, genetic testing. transmission:

Assoc. Prof. TS.BS Ho Sy Hung - Deputy Director of the National Center for Reproductive Support, National Hospital of Obstetrics and Gynecology
• Dr. Pham Dinh Minh - Director of Research and Development Center GENTIS


At the talkshow, Assoc. Prof. TS.BS Ho Sy Hung shared his knowledge, information and clinical experience when practicing mosaic embryo transfer, as well as the latest instructions and updates on how to handle mosaic embryo transfer in reality.
In the field of assisted reproduction, mosaicism is a concept that refers to the presence of cells with different genotypes in the same embryo. Can be identified with blastocyst biopsy – taking multiple TE cells. Based on the percentage of abnormal cells, we can diagnose it as mosaic.
Dr. Hung added, the results of PGT-A are affected from the biopsy site; the sensitivity and specificity of the PGT-A implementation platform; Analytical techniques, software used and threshold settings for mosaic interpretation. When transferring mosaic embryos, pregnancy rates can be achieved as desired. Note that the pregnancy outcome of mosaic embryo transfer is poorer than that of haploid embryo transfer, and pregnancy rates may not be different with unscreened embryo transfer.
According to Assoc. Prof. Ho Sy Hung, in embryo testing, there are cases that are very easy to handle, we get completely normal embryos. There are cases that we rule out as soon as the embryo has a very severe abnormality, never to be transferred. However, there are situations where we don't know how to handle it, what will happen if it is transferred to the patient, if not transferred and left, there is a fee, will it miss the opportunity for couples who have been infertile for many years?

Therefore, genetics associations have made recommendations based on a number of studies to provide the greatest consensus: Preimplantation Genetic Diagnostics International Society (PGDIS) 2016, 2019; Preimplantation Genetic Diagnostics International Consortium (PGDIS) 2021; CoGEN 2017. Based on these data, the following clinical guidelines have been proposed:

• Priority is given to normal embryo transfer (whole set)
• If there is no normal embryo, advise doing the next IVF cycle
• Consider transfer of mosaic embryos in cases
- No normal embryos after IVF/PGT-A . cycle(s)
- All normal embryos have been transferred
• Patients choosing mosaic embryo transfer must be fully counseled by a clinical geneticist regarding PGT-A results and possible clinical outcomes. The decision to transfer mosaic embryos is made after careful consideration of the benefits, risks, and alternatives.

The parameters to evaluate the selection of mosaic embryos are the degree of mosaicism, the specific chromosomes being mosaicized, monosomy or trisomy, the mosaic of both chromosomes or part of the chromosomes, the number of mosaic chromosomes (one, two) or more) and prenatal/postnatal screening: Karyotype or microarray.
In response to a question from Dr. Hien in Phu Tho, Assoc. Prof. TS.BS Ho Sy Hung said, in case if the couple doing IVF do not have a haploid embryo to transfer, we will come back to find out how they do. If an older couple doesn't have many opportunities to create normal embryos and it doesn't cost much to do more IVF or testing, now we have to consider and transfer mosaic embryos to people. If this couple is young and ready for another cycle of IVF, we should consider doing another cycle of IVF.
Note that couples who have been infertile for many years, are older, their husbands have abnormal sperm, and have a history of repeated miscarriages are the groups that do IVF that will have a higher risk of creating mosaic embryos.

Currently, GENTIS is one of the pioneers in Vietnam in providing fertility tests. Dr. Pham Dinh Minh said that, compared to other units, GENTIS has always demonstrated its superiority and difference in technology and ensured the accuracy of pre-embryo genetic testing. GENTIS is applying the latest PGT testing technologies such as: PGT MAX 1, ONE PGT-M, specifically as follows:

PGT - MAX 1 - High resolution PGT test detects:
- Complete aneuploidy of 24 chromosomes
- Structural abnormalities (addition, deletion): > 5 Mb
- 2 abnormalities with loss of segments >2 Mb in size:
Deletion of 22q11.2 (associated with DiGeorge syndrome)
+ 1p36 deletion (associated with 1p36 deletion syndrome)
1. ONE PGT-M helps to optimize the cost and time of testing for single gene disease (PGT-M). This method is performed for couples who are at risk of passing on single-gene disorders to the next generation.
2. In addition, GENTIS also researches and develops other pre-implantation genetic tests to detect more embryo abnormalities such as PGT-A (Detects 24 chromosome abnormalities in embryos), PGT -SR (Detecting Abnormalities of embryo chromosome structure with size >5Mb), PGT-M (Detecting genetic abnormalities of single gene diseases such as Thalassemia, Myelodystrophy, Adrenal hyperplasia...), method that combines both PGT-A/SR and PGT-M,...

GENTIS promises to always try non-stop to make each process and each result the most accurate and rigorous, fulfilling the mission of improving the physical and mental health of the Vietnamese people.
Hopefully, the useful information shared by the two experts in the talk show "Genetics Counseling - Discussing with Experts" this time will help doctors and the audience better understand the issues surrounding mosaic embryo transfer. GENTIS will continue to bring more meaningful programs to serve doctors and customers.
            [content_more] => 
            [meta_title] => Genetic counseling with experts: "Mosaic embryo transfer - Clinical reality and management"
            [meta_description] => 
            [meta_keyword] => 
            [thumbnail_alt] => 
            [post_id] => 1087
            [category_id] => 4
        )

)